Osawa M, Matsuda Y, Kinoshita Y, Wakai T, et al. Urokinase-type Plasminogen Activator Is a Therapeutic Target for Overcoming Sorafenib Resistance in Hepatoma Cells. Anticancer Res 2021;41:645-660.
PMID: 33517269